Retatrutide (40 mg)

Retatrutide is an experimental weight-loss and diabetes medication 

It is a triple hormone receptor agonist, meaning it activates three different receptors in the body:

- GLP-1 (glucagon-like peptide-1) receptor

- GIP (glucose-dependent insulinotropic polypeptide) receptor

- Glucagon receptor

What it does

By targeting all three pathways, retatrutide aims to:

- Reduce appetite

- Increase feelings of fullness

- Improve blood sugar control

- Increase energy expenditure (calorie burning)